BAJAJ HEALTHCARE
Quarterly Results Analysis [Dec2024]
BAJAJ HEALTHCARE Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹123 Cr | ₹133 Cr | ₹132 Cr | ₹134 Cr | ₹109 Cr | ₹101 Cr | ₹130 Cr | ₹154 Cr |
Expenses | ₹101 Cr | ₹109 Cr | ₹108 Cr | ₹118 Cr | ₹89 Cr | ₹82 Cr | ₹108 Cr | ₹132 Cr |
Operating Income | ₹22 Cr | ₹25 Cr | ₹25 Cr | ₹16 Cr | ₹20 Cr | ₹19 Cr | ₹22 Cr | ₹22 Cr |
Other Income | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹6 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
Interest | ₹6 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹9 Cr | ₹6 Cr |
Depreciation | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr |
Profit Before Tax | ₹12 Cr | ₹12 Cr | ₹10 Cr | ₹-35 Cr | ₹6 Cr | ₹5 Cr | ₹7 Cr | ₹12 Cr |
Profit After Tax | ₹15 Cr | ₹8 Cr | ₹8 Cr | ₹-32 Cr | ₹6 Cr | ₹5 Cr | ₹7 Cr | ₹11 Cr |
EPS | ₹4.74 | ₹2.64 | ₹2.91 | ₹-11.60 | ₹2.00 | ₹1.86 | ₹2.55 | ₹4.04 |
Industry Peers & Returns | 1W | 1M | 1Y |
BAJAJ HEALTHCARE | -1.6% | -9.5% | 91.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2.8% | -7.5% | 2.3% |
DIVIS LABORATORIES | -0.2% | -9.9% | 60.4% |
CIPLA | 4.4% | -0.6% | -1% |
TORRENT PHARMACEUTICALS | 4.8% | -2.9% | 15.4% |
DR REDDYS LABORATORIES | NA | -9.4% | -10.2% |
MANKIND PHARMA | -0.7% | -8.8% | 7.1% |
ZYDUS LIFESCIENCES | 2.5% | -11.4% | -5.5% |
LUPIN | 2.9% | -8.1% | 20.9% |
BAJAJ HEALTHCARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -7.74 % |
Y-o-Y | 13.10 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹123 Cr | -7.74 | |
Sep2024 | ₹133 Cr | 0.64 | |
Jun2024 | ₹132 Cr | -1.23 | |
Mar2024 | ₹134 Cr | 23.33 | |
Dec2023 | ₹109 Cr | 7.27 | |
Sep2023 | ₹101 Cr | -21.99 | |
Jun2023 | ₹130 Cr | -15.82 | |
Mar2023 | ₹154 Cr | - |
BAJAJ HEALTHCARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -11.76 % |
Y-o-Y | 10.77 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹22 Cr | -11.76 | |
Sep2024 | ₹25 Cr | 0.08 | |
Jun2024 | ₹25 Cr | 52.83 | |
Mar2024 | ₹16 Cr | -17.93 | |
Dec2023 | ₹20 Cr | 3.09 | |
Sep2023 | ₹19 Cr | -12.84 | |
Jun2023 | ₹22 Cr | -1.27 | |
Mar2023 | ₹22 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -4.40 % |
Y-o-Y | -2.06 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 17.62% | -4.40 | |
Sep2024 | 18.43% | -0.54 | |
Jun2024 | 18.53% | 54.80 | |
Mar2024 | 11.97% | -33.46 | |
Dec2023 | 17.99% | -3.90 | |
Sep2023 | 18.72% | 11.69 | |
Jun2023 | 16.76% | 17.28 | |
Mar2023 | 14.29% | - |
BAJAJ HEALTHCARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 79.38 % |
Y-o-Y | 170.93 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹15 Cr | 79.38 | |
Sep2024 | ₹8 Cr | 3.95 | |
Jun2024 | ₹8 Cr | Positive | |
Mar2024 | ₹-32 Cr | Negative | |
Dec2023 | ₹6 Cr | 7.81 | |
Sep2023 | ₹5 Cr | -27.07 | |
Jun2023 | ₹7 Cr | -37.00 | |
Mar2023 | ₹11 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 94.42 % |
Y-o-Y | 139.49 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 12.19 % | 94.42 | |
Sep2024 | 6.27 % | 3.29 | |
Jun2024 | 6.07 % | Positive | |
Mar2024 | -23.9 % | Negative | |
Dec2023 | 5.09 % | 0.59 | |
Sep2023 | 5.06 % | -6.64 | |
Jun2023 | 5.42 % | -25.14 | |
Mar2023 | 7.24 % | - |
BAJAJ HEALTHCARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 79.55 % |
Y-o-Y | 137.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹4.74 | 79.55 | |
Sep2024 | ₹2.64 | -9.28 | |
Jun2024 | ₹2.91 | Positive | |
Mar2024 | ₹-11.6 | Negative | |
Dec2023 | ₹2 | 7.53 | |
Sep2023 | ₹1.86 | -27.06 | |
Jun2023 | ₹2.55 | -36.88 | |
Mar2023 | ₹4.04 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD